nodes	percent_of_prediction	percent_of_DWPC	metapath
Lubiprostone—CLCN2—Stimuli-sensing channels—TRPV3—atopic dermatitis	0.0312	0.468	CbGpPWpGaD
Lubiprostone—CLCN2—Ion channel transport—TRPV3—atopic dermatitis	0.0203	0.306	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.00708	0.106	CbGpPWpGaD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	0.0026	0.0391	CbGpPWpGaD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.00175	0.0263	CbGpPWpGaD
Lubiprostone—Dyspepsia—Tacrolimus—atopic dermatitis	0.00158	0.0017	CcSEcCtD
Lubiprostone—Dizziness—Fluocinolone Acetonide—atopic dermatitis	0.00157	0.00168	CcSEcCtD
Lubiprostone—Nausea—Loratadine—atopic dermatitis	0.00156	0.00168	CcSEcCtD
Lubiprostone—Decreased appetite—Tacrolimus—atopic dermatitis	0.00156	0.00168	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Tacrolimus—atopic dermatitis	0.00155	0.00166	CcSEcCtD
Lubiprostone—Connective tissue disorder—Hydrocortisone—atopic dermatitis	0.00155	0.00166	CcSEcCtD
Lubiprostone—Fatigue—Tacrolimus—atopic dermatitis	0.00155	0.00166	CcSEcCtD
Lubiprostone—Diarrhoea—Mometasone—atopic dermatitis	0.00155	0.00166	CcSEcCtD
Lubiprostone—Constipation—Tacrolimus—atopic dermatitis	0.00154	0.00165	CcSEcCtD
Lubiprostone—Pain—Tacrolimus—atopic dermatitis	0.00154	0.00165	CcSEcCtD
Lubiprostone—Weight increased—Dexamethasone—atopic dermatitis	0.00153	0.00164	CcSEcCtD
Lubiprostone—Weight increased—Betamethasone—atopic dermatitis	0.00153	0.00164	CcSEcCtD
Lubiprostone—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.00151	0.00161	CcSEcCtD
Lubiprostone—Alanine aminotransferase increased—Prednisone—atopic dermatitis	0.0015	0.00161	CcSEcCtD
Lubiprostone—Rash—Fluocinolone Acetonide—atopic dermatitis	0.00149	0.0016	CcSEcCtD
Lubiprostone—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.00149	0.0016	CcSEcCtD
Lubiprostone—Headache—Fluocinolone Acetonide—atopic dermatitis	0.00148	0.00159	CcSEcCtD
Lubiprostone—Feeling abnormal—Tacrolimus—atopic dermatitis	0.00148	0.00159	CcSEcCtD
Lubiprostone—Abdominal distension—Prednisone—atopic dermatitis	0.00148	0.00158	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Tacrolimus—atopic dermatitis	0.00147	0.00158	CcSEcCtD
Lubiprostone—Connective tissue disorder—Methylprednisolone—atopic dermatitis	0.00146	0.00156	CcSEcCtD
Lubiprostone—Vomiting—Mometasone—atopic dermatitis	0.00144	0.00154	CcSEcCtD
Lubiprostone—Rash—Mometasone—atopic dermatitis	0.00143	0.00153	CcSEcCtD
Lubiprostone—Dermatitis—Mometasone—atopic dermatitis	0.00142	0.00153	CcSEcCtD
Lubiprostone—Abdominal pain—Tacrolimus—atopic dermatitis	0.00142	0.00152	CcSEcCtD
Lubiprostone—Headache—Mometasone—atopic dermatitis	0.00142	0.00152	CcSEcCtD
Lubiprostone—Erythema—Prednisolone—atopic dermatitis	0.00141	0.00151	CcSEcCtD
Lubiprostone—Nausea—Fluocinolone Acetonide—atopic dermatitis	0.00141	0.00151	CcSEcCtD
Lubiprostone—Mental disorder—Hydrocortisone—atopic dermatitis	0.00138	0.00148	CcSEcCtD
Lubiprostone—Malnutrition—Hydrocortisone—atopic dermatitis	0.00138	0.00147	CcSEcCtD
Lubiprostone—Erythema—Hydrocortisone—atopic dermatitis	0.00138	0.00147	CcSEcCtD
Lubiprostone—Nausea—Mometasone—atopic dermatitis	0.00134	0.00144	CcSEcCtD
Lubiprostone—Mediastinal disorder—Methylprednisolone—atopic dermatitis	0.00134	0.00143	CcSEcCtD
Lubiprostone—Weight increased—Prednisone—atopic dermatitis	0.00134	0.00143	CcSEcCtD
Lubiprostone—Hypersensitivity—Tacrolimus—atopic dermatitis	0.00133	0.00142	CcSEcCtD
Lubiprostone—Ill-defined disorder—Prednisolone—atopic dermatitis	0.00131	0.0014	CcSEcCtD
Lubiprostone—Mental disorder—Methylprednisolone—atopic dermatitis	0.0013	0.00139	CcSEcCtD
Lubiprostone—Erythema—Triamcinolone—atopic dermatitis	0.0013	0.00139	CcSEcCtD
Lubiprostone—Erythema—Methylprednisolone—atopic dermatitis	0.00129	0.00138	CcSEcCtD
Lubiprostone—Malnutrition—Methylprednisolone—atopic dermatitis	0.00129	0.00138	CcSEcCtD
Lubiprostone—Asthenia—Tacrolimus—atopic dermatitis	0.00129	0.00138	CcSEcCtD
Lubiprostone—Ill-defined disorder—Hydrocortisone—atopic dermatitis	0.00128	0.00137	CcSEcCtD
Lubiprostone—Malaise—Prednisolone—atopic dermatitis	0.00127	0.00136	CcSEcCtD
Lubiprostone—Dysgeusia—Triamcinolone—atopic dermatitis	0.00127	0.00136	CcSEcCtD
Lubiprostone—Syncope—Prednisolone—atopic dermatitis	0.00126	0.00135	CcSEcCtD
Lubiprostone—CLCN2—Transmembrane transport of small molecules—PPARA—atopic dermatitis	0.00126	0.0189	CbGpPWpGaD
Lubiprostone—Malaise—Hydrocortisone—atopic dermatitis	0.00124	0.00133	CcSEcCtD
Lubiprostone—Loss of consciousness—Prednisolone—atopic dermatitis	0.00124	0.00133	CcSEcCtD
Lubiprostone—Syncope—Hydrocortisone—atopic dermatitis	0.00123	0.00132	CcSEcCtD
Lubiprostone—Diarrhoea—Tacrolimus—atopic dermatitis	0.00123	0.00132	CcSEcCtD
Lubiprostone—Loss of consciousness—Hydrocortisone—atopic dermatitis	0.00121	0.0013	CcSEcCtD
Lubiprostone—Ill-defined disorder—Triamcinolone—atopic dermatitis	0.0012	0.00129	CcSEcCtD
Lubiprostone—Ill-defined disorder—Methylprednisolone—atopic dermatitis	0.0012	0.00128	CcSEcCtD
Lubiprostone—Dizziness—Tacrolimus—atopic dermatitis	0.00119	0.00127	CcSEcCtD
Lubiprostone—Discomfort—Prednisolone—atopic dermatitis	0.00118	0.00127	CcSEcCtD
Lubiprostone—Erythema—Dexamethasone—atopic dermatitis	0.00118	0.00126	CcSEcCtD
Lubiprostone—Erythema—Betamethasone—atopic dermatitis	0.00118	0.00126	CcSEcCtD
Lubiprostone—Myalgia—Hydrocortisone—atopic dermatitis	0.00117	0.00125	CcSEcCtD
Lubiprostone—Malaise—Triamcinolone—atopic dermatitis	0.00117	0.00125	CcSEcCtD
Lubiprostone—Anxiety—Hydrocortisone—atopic dermatitis	0.00117	0.00125	CcSEcCtD
Lubiprostone—Malaise—Methylprednisolone—atopic dermatitis	0.00117	0.00125	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—atopic dermatitis	0.00116	0.00125	CcSEcCtD
Lubiprostone—Syncope—Triamcinolone—atopic dermatitis	0.00116	0.00124	CcSEcCtD
Lubiprostone—Syncope—Methylprednisolone—atopic dermatitis	0.00116	0.00124	CcSEcCtD
Lubiprostone—Discomfort—Hydrocortisone—atopic dermatitis	0.00116	0.00124	CcSEcCtD
Lubiprostone—Connective tissue disorder—Prednisone—atopic dermatitis	0.00116	0.00124	CcSEcCtD
Lubiprostone—Oedema—Prednisolone—atopic dermatitis	0.00115	0.00123	CcSEcCtD
Lubiprostone—Vomiting—Tacrolimus—atopic dermatitis	0.00114	0.00123	CcSEcCtD
Lubiprostone—Loss of consciousness—Triamcinolone—atopic dermatitis	0.00114	0.00122	CcSEcCtD
Lubiprostone—Loss of consciousness—Methylprednisolone—atopic dermatitis	0.00114	0.00122	CcSEcCtD
Lubiprostone—Rash—Tacrolimus—atopic dermatitis	0.00113	0.00122	CcSEcCtD
Lubiprostone—Dermatitis—Tacrolimus—atopic dermatitis	0.00113	0.00121	CcSEcCtD
Lubiprostone—Shock—Prednisolone—atopic dermatitis	0.00113	0.00121	CcSEcCtD
Lubiprostone—Cough—Triamcinolone—atopic dermatitis	0.00113	0.00121	CcSEcCtD
Lubiprostone—Headache—Tacrolimus—atopic dermatitis	0.00113	0.00121	CcSEcCtD
Lubiprostone—Oedema—Hydrocortisone—atopic dermatitis	0.00112	0.0012	CcSEcCtD
Lubiprostone—Tachycardia—Prednisolone—atopic dermatitis	0.00112	0.0012	CcSEcCtD
Lubiprostone—Hyperhidrosis—Prednisolone—atopic dermatitis	0.00111	0.00119	CcSEcCtD
Lubiprostone—Shock—Hydrocortisone—atopic dermatitis	0.0011	0.00118	CcSEcCtD
Lubiprostone—Myalgia—Triamcinolone—atopic dermatitis	0.0011	0.00118	CcSEcCtD
Lubiprostone—Nervous system disorder—Hydrocortisone—atopic dermatitis	0.0011	0.00118	CcSEcCtD
Lubiprostone—Myalgia—Methylprednisolone—atopic dermatitis	0.0011	0.00118	CcSEcCtD
Lubiprostone—Anxiety—Methylprednisolone—atopic dermatitis	0.0011	0.00117	CcSEcCtD
Lubiprostone—Tachycardia—Hydrocortisone—atopic dermatitis	0.0011	0.00117	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—atopic dermatitis	0.00109	0.00117	CcSEcCtD
Lubiprostone—Skin disorder—Hydrocortisone—atopic dermatitis	0.00109	0.00117	CcSEcCtD
Lubiprostone—Ill-defined disorder—Dexamethasone—atopic dermatitis	0.00109	0.00117	CcSEcCtD
Lubiprostone—Ill-defined disorder—Betamethasone—atopic dermatitis	0.00109	0.00117	CcSEcCtD
Lubiprostone—Discomfort—Triamcinolone—atopic dermatitis	0.00109	0.00117	CcSEcCtD
Lubiprostone—Discomfort—Methylprednisolone—atopic dermatitis	0.00109	0.00116	CcSEcCtD
Lubiprostone—Hyperhidrosis—Hydrocortisone—atopic dermatitis	0.00109	0.00116	CcSEcCtD
Lubiprostone—Dry mouth—Triamcinolone—atopic dermatitis	0.00108	0.00116	CcSEcCtD
Lubiprostone—Anorexia—Hydrocortisone—atopic dermatitis	0.00107	0.00115	CcSEcCtD
Lubiprostone—Nausea—Tacrolimus—atopic dermatitis	0.00107	0.00115	CcSEcCtD
Lubiprostone—Malaise—Dexamethasone—atopic dermatitis	0.00106	0.00114	CcSEcCtD
Lubiprostone—Malaise—Betamethasone—atopic dermatitis	0.00106	0.00114	CcSEcCtD
Lubiprostone—Oedema—Triamcinolone—atopic dermatitis	0.00106	0.00113	CcSEcCtD
Lubiprostone—Syncope—Dexamethasone—atopic dermatitis	0.00105	0.00113	CcSEcCtD
Lubiprostone—Syncope—Betamethasone—atopic dermatitis	0.00105	0.00113	CcSEcCtD
Lubiprostone—Shock—Triamcinolone—atopic dermatitis	0.00104	0.00111	CcSEcCtD
Lubiprostone—Shock—Methylprednisolone—atopic dermatitis	0.00104	0.00111	CcSEcCtD
Lubiprostone—Nervous system disorder—Methylprednisolone—atopic dermatitis	0.00103	0.00111	CcSEcCtD
Lubiprostone—Loss of consciousness—Betamethasone—atopic dermatitis	0.00103	0.00111	CcSEcCtD
Lubiprostone—Loss of consciousness—Dexamethasone—atopic dermatitis	0.00103	0.00111	CcSEcCtD
Lubiprostone—Tachycardia—Triamcinolone—atopic dermatitis	0.00103	0.00111	CcSEcCtD
Lubiprostone—Mental disorder—Prednisone—atopic dermatitis	0.00103	0.0011	CcSEcCtD
Lubiprostone—Tachycardia—Methylprednisolone—atopic dermatitis	0.00103	0.0011	CcSEcCtD
Lubiprostone—Skin disorder—Methylprednisolone—atopic dermatitis	0.00102	0.0011	CcSEcCtD
Lubiprostone—Malnutrition—Prednisone—atopic dermatitis	0.00102	0.0011	CcSEcCtD
Lubiprostone—Erythema—Prednisone—atopic dermatitis	0.00102	0.0011	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.00102	0.0011	CcSEcCtD
Lubiprostone—Hyperhidrosis—Triamcinolone—atopic dermatitis	0.00102	0.00109	CcSEcCtD
Lubiprostone—Hyperhidrosis—Methylprednisolone—atopic dermatitis	0.00102	0.00109	CcSEcCtD
Lubiprostone—Myalgia—Betamethasone—atopic dermatitis	0.001	0.00107	CcSEcCtD
Lubiprostone—Myalgia—Dexamethasone—atopic dermatitis	0.001	0.00107	CcSEcCtD
Lubiprostone—Anxiety—Dexamethasone—atopic dermatitis	0.000997	0.00107	CcSEcCtD
Lubiprostone—Anxiety—Betamethasone—atopic dermatitis	0.000997	0.00107	CcSEcCtD
Lubiprostone—Discomfort—Betamethasone—atopic dermatitis	0.000988	0.00106	CcSEcCtD
Lubiprostone—Discomfort—Dexamethasone—atopic dermatitis	0.000988	0.00106	CcSEcCtD
Lubiprostone—Dyspepsia—Hydrocortisone—atopic dermatitis	0.000988	0.00106	CcSEcCtD
Lubiprostone—Pain—Prednisolone—atopic dermatitis	0.000983	0.00105	CcSEcCtD
Lubiprostone—Decreased appetite—Hydrocortisone—atopic dermatitis	0.000976	0.00105	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000969	0.00104	CcSEcCtD
Lubiprostone—Fatigue—Hydrocortisone—atopic dermatitis	0.000968	0.00104	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.000963	0.00103	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.000961	0.00103	CcSEcCtD
Lubiprostone—Pain—Hydrocortisone—atopic dermatitis	0.00096	0.00103	CcSEcCtD
Lubiprostone—Oedema—Dexamethasone—atopic dermatitis	0.000959	0.00103	CcSEcCtD
Lubiprostone—Oedema—Betamethasone—atopic dermatitis	0.000959	0.00103	CcSEcCtD
Lubiprostone—Ill-defined disorder—Prednisone—atopic dermatitis	0.00095	0.00102	CcSEcCtD
Lubiprostone—Feeling abnormal—Prednisolone—atopic dermatitis	0.000947	0.00101	CcSEcCtD
Lubiprostone—Shock—Betamethasone—atopic dermatitis	0.000944	0.00101	CcSEcCtD
Lubiprostone—Shock—Dexamethasone—atopic dermatitis	0.000944	0.00101	CcSEcCtD
Lubiprostone—Dyspnoea—Triamcinolone—atopic dermatitis	0.000942	0.00101	CcSEcCtD
Lubiprostone—Nervous system disorder—Betamethasone—atopic dermatitis	0.000941	0.00101	CcSEcCtD
Lubiprostone—Nervous system disorder—Dexamethasone—atopic dermatitis	0.000941	0.00101	CcSEcCtD
Lubiprostone—Tachycardia—Dexamethasone—atopic dermatitis	0.000936	0.001	CcSEcCtD
Lubiprostone—Tachycardia—Betamethasone—atopic dermatitis	0.000936	0.001	CcSEcCtD
Lubiprostone—Dyspepsia—Triamcinolone—atopic dermatitis	0.00093	0.000997	CcSEcCtD
Lubiprostone—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000928	0.000995	CcSEcCtD
Lubiprostone—Hyperhidrosis—Betamethasone—atopic dermatitis	0.000927	0.000993	CcSEcCtD
Lubiprostone—Hyperhidrosis—Dexamethasone—atopic dermatitis	0.000927	0.000993	CcSEcCtD
Lubiprostone—Feeling abnormal—Hydrocortisone—atopic dermatitis	0.000925	0.000991	CcSEcCtD
Lubiprostone—Malaise—Prednisone—atopic dermatitis	0.000923	0.000989	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Hydrocortisone—atopic dermatitis	0.000918	0.000983	CcSEcCtD
Lubiprostone—Syncope—Prednisone—atopic dermatitis	0.000918	0.000983	CcSEcCtD
Lubiprostone—Anorexia—Dexamethasone—atopic dermatitis	0.000914	0.000979	CcSEcCtD
Lubiprostone—Anorexia—Betamethasone—atopic dermatitis	0.000914	0.000979	CcSEcCtD
Lubiprostone—Fatigue—Triamcinolone—atopic dermatitis	0.000911	0.000976	CcSEcCtD
Lubiprostone—Fatigue—Methylprednisolone—atopic dermatitis	0.000909	0.000974	CcSEcCtD
Lubiprostone—Pain—Triamcinolone—atopic dermatitis	0.000904	0.000968	CcSEcCtD
Lubiprostone—Loss of consciousness—Prednisone—atopic dermatitis	0.000899	0.000964	CcSEcCtD
Lubiprostone—Abdominal pain—Hydrocortisone—atopic dermatitis	0.000887	0.000951	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	0.000874	0.000936	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	0.000874	0.000936	CcSEcCtD
Lubiprostone—Myalgia—Prednisone—atopic dermatitis	0.000871	0.000933	CcSEcCtD
Lubiprostone—Feeling abnormal—Triamcinolone—atopic dermatitis	0.000871	0.000933	CcSEcCtD
Lubiprostone—Feeling abnormal—Methylprednisolone—atopic dermatitis	0.000869	0.000931	CcSEcCtD
Lubiprostone—Anxiety—Prednisone—atopic dermatitis	0.000868	0.00093	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—atopic dermatitis	0.000865	0.000927	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Methylprednisolone—atopic dermatitis	0.000862	0.000924	CcSEcCtD
Lubiprostone—Discomfort—Prednisone—atopic dermatitis	0.000861	0.000922	CcSEcCtD
Lubiprostone—Hypersensitivity—Prednisolone—atopic dermatitis	0.000847	0.000907	CcSEcCtD
Lubiprostone—Dyspepsia—Dexamethasone—atopic dermatitis	0.000844	0.000904	CcSEcCtD
Lubiprostone—Dyspepsia—Betamethasone—atopic dermatitis	0.000844	0.000904	CcSEcCtD
Lubiprostone—Oedema—Prednisone—atopic dermatitis	0.000835	0.000895	CcSEcCtD
Lubiprostone—Abdominal pain—Methylprednisolone—atopic dermatitis	0.000834	0.000893	CcSEcCtD
Lubiprostone—Decreased appetite—Dexamethasone—atopic dermatitis	0.000834	0.000893	CcSEcCtD
Lubiprostone—Decreased appetite—Betamethasone—atopic dermatitis	0.000834	0.000893	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.000828	0.000887	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.000828	0.000887	CcSEcCtD
Lubiprostone—Hypersensitivity—Hydrocortisone—atopic dermatitis	0.000827	0.000886	CcSEcCtD
Lubiprostone—Fatigue—Betamethasone—atopic dermatitis	0.000827	0.000886	CcSEcCtD
Lubiprostone—Fatigue—Dexamethasone—atopic dermatitis	0.000827	0.000886	CcSEcCtD
Lubiprostone—Shock—Prednisone—atopic dermatitis	0.000822	0.00088	CcSEcCtD
Lubiprostone—Pain—Dexamethasone—atopic dermatitis	0.00082	0.000879	CcSEcCtD
Lubiprostone—Pain—Betamethasone—atopic dermatitis	0.00082	0.000879	CcSEcCtD
Lubiprostone—Nervous system disorder—Prednisone—atopic dermatitis	0.000819	0.000877	CcSEcCtD
Lubiprostone—Tachycardia—Prednisone—atopic dermatitis	0.000815	0.000873	CcSEcCtD
Lubiprostone—Skin disorder—Prednisone—atopic dermatitis	0.000811	0.000869	CcSEcCtD
Lubiprostone—Hyperhidrosis—Prednisone—atopic dermatitis	0.000807	0.000865	CcSEcCtD
Lubiprostone—Asthenia—Hydrocortisone—atopic dermatitis	0.000805	0.000863	CcSEcCtD
Lubiprostone—Anorexia—Prednisone—atopic dermatitis	0.000796	0.000853	CcSEcCtD
Lubiprostone—Feeling abnormal—Dexamethasone—atopic dermatitis	0.00079	0.000847	CcSEcCtD
Lubiprostone—Feeling abnormal—Betamethasone—atopic dermatitis	0.00079	0.000847	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Betamethasone—atopic dermatitis	0.000784	0.00084	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Dexamethasone—atopic dermatitis	0.000784	0.00084	CcSEcCtD
Lubiprostone—Hypersensitivity—Triamcinolone—atopic dermatitis	0.000779	0.000834	CcSEcCtD
Lubiprostone—CBR1—Metabolism—GLB1—atopic dermatitis	0.000778	0.0117	CbGpPWpGaD
Lubiprostone—Hypersensitivity—Methylprednisolone—atopic dermatitis	0.000777	0.000832	CcSEcCtD
Lubiprostone—Diarrhoea—Hydrocortisone—atopic dermatitis	0.000768	0.000823	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Prednisone—atopic dermatitis	0.000761	0.000815	CcSEcCtD
Lubiprostone—Dizziness—Prednisolone—atopic dermatitis	0.00076	0.000814	CcSEcCtD
Lubiprostone—Asthenia—Triamcinolone—atopic dermatitis	0.000758	0.000812	CcSEcCtD
Lubiprostone—Abdominal pain—Dexamethasone—atopic dermatitis	0.000758	0.000812	CcSEcCtD
Lubiprostone—Abdominal pain—Betamethasone—atopic dermatitis	0.000758	0.000812	CcSEcCtD
Lubiprostone—Asthenia—Methylprednisolone—atopic dermatitis	0.000757	0.000811	CcSEcCtD
Lubiprostone—CBR1—Metabolism—ADSL—atopic dermatitis	0.000746	0.0112	CbGpPWpGaD
Lubiprostone—Dizziness—Hydrocortisone—atopic dermatitis	0.000742	0.000795	CcSEcCtD
Lubiprostone—Dyspepsia—Prednisone—atopic dermatitis	0.000735	0.000788	CcSEcCtD
Lubiprostone—Decreased appetite—Prednisone—atopic dermatitis	0.000726	0.000778	CcSEcCtD
Lubiprostone—Rash—Prednisolone—atopic dermatitis	0.000725	0.000776	CcSEcCtD
Lubiprostone—Dermatitis—Prednisolone—atopic dermatitis	0.000724	0.000776	CcSEcCtD
Lubiprostone—Diarrhoea—Methylprednisolone—atopic dermatitis	0.000722	0.000773	CcSEcCtD
Lubiprostone—Fatigue—Prednisone—atopic dermatitis	0.00072	0.000771	CcSEcCtD
Lubiprostone—Headache—Prednisolone—atopic dermatitis	0.00072	0.000771	CcSEcCtD
Lubiprostone—Constipation—Prednisone—atopic dermatitis	0.000714	0.000765	CcSEcCtD
Lubiprostone—Vomiting—Hydrocortisone—atopic dermatitis	0.000714	0.000765	CcSEcCtD
Lubiprostone—Rash—Hydrocortisone—atopic dermatitis	0.000708	0.000758	CcSEcCtD
Lubiprostone—Dermatitis—Hydrocortisone—atopic dermatitis	0.000707	0.000758	CcSEcCtD
Lubiprostone—Headache—Hydrocortisone—atopic dermatitis	0.000703	0.000753	CcSEcCtD
Lubiprostone—Dizziness—Triamcinolone—atopic dermatitis	0.000699	0.000749	CcSEcCtD
Lubiprostone—Dizziness—Methylprednisolone—atopic dermatitis	0.000697	0.000747	CcSEcCtD
Lubiprostone—Feeling abnormal—Prednisone—atopic dermatitis	0.000688	0.000737	CcSEcCtD
Lubiprostone—Asthenia—Dexamethasone—atopic dermatitis	0.000688	0.000737	CcSEcCtD
Lubiprostone—Asthenia—Betamethasone—atopic dermatitis	0.000688	0.000737	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Prednisone—atopic dermatitis	0.000683	0.000732	CcSEcCtD
Lubiprostone—Nausea—Prednisolone—atopic dermatitis	0.000683	0.000731	CcSEcCtD
Lubiprostone—Vomiting—Triamcinolone—atopic dermatitis	0.000672	0.00072	CcSEcCtD
Lubiprostone—Vomiting—Methylprednisolone—atopic dermatitis	0.000671	0.000718	CcSEcCtD
Lubiprostone—Nausea—Hydrocortisone—atopic dermatitis	0.000667	0.000714	CcSEcCtD
Lubiprostone—Rash—Triamcinolone—atopic dermatitis	0.000666	0.000714	CcSEcCtD
Lubiprostone—Dermatitis—Triamcinolone—atopic dermatitis	0.000666	0.000713	CcSEcCtD
Lubiprostone—Rash—Methylprednisolone—atopic dermatitis	0.000665	0.000712	CcSEcCtD
Lubiprostone—Dermatitis—Methylprednisolone—atopic dermatitis	0.000664	0.000712	CcSEcCtD
Lubiprostone—Headache—Triamcinolone—atopic dermatitis	0.000662	0.000709	CcSEcCtD
Lubiprostone—Headache—Methylprednisolone—atopic dermatitis	0.000661	0.000708	CcSEcCtD
Lubiprostone—Abdominal pain—Prednisone—atopic dermatitis	0.00066	0.000707	CcSEcCtD
Lubiprostone—Diarrhoea—Betamethasone—atopic dermatitis	0.000656	0.000703	CcSEcCtD
Lubiprostone—Diarrhoea—Dexamethasone—atopic dermatitis	0.000656	0.000703	CcSEcCtD
Lubiprostone—Dizziness—Dexamethasone—atopic dermatitis	0.000634	0.000679	CcSEcCtD
Lubiprostone—Dizziness—Betamethasone—atopic dermatitis	0.000634	0.000679	CcSEcCtD
Lubiprostone—Nausea—Triamcinolone—atopic dermatitis	0.000628	0.000673	CcSEcCtD
Lubiprostone—Nausea—Methylprednisolone—atopic dermatitis	0.000626	0.000671	CcSEcCtD
Lubiprostone—Hypersensitivity—Prednisone—atopic dermatitis	0.000615	0.000659	CcSEcCtD
Lubiprostone—Vomiting—Dexamethasone—atopic dermatitis	0.00061	0.000653	CcSEcCtD
Lubiprostone—Vomiting—Betamethasone—atopic dermatitis	0.00061	0.000653	CcSEcCtD
Lubiprostone—Rash—Dexamethasone—atopic dermatitis	0.000605	0.000648	CcSEcCtD
Lubiprostone—Rash—Betamethasone—atopic dermatitis	0.000605	0.000648	CcSEcCtD
Lubiprostone—Dermatitis—Dexamethasone—atopic dermatitis	0.000604	0.000647	CcSEcCtD
Lubiprostone—Dermatitis—Betamethasone—atopic dermatitis	0.000604	0.000647	CcSEcCtD
Lubiprostone—Headache—Betamethasone—atopic dermatitis	0.000601	0.000644	CcSEcCtD
Lubiprostone—Headache—Dexamethasone—atopic dermatitis	0.000601	0.000644	CcSEcCtD
Lubiprostone—Asthenia—Prednisone—atopic dermatitis	0.000599	0.000642	CcSEcCtD
Lubiprostone—Diarrhoea—Prednisone—atopic dermatitis	0.000571	0.000612	CcSEcCtD
Lubiprostone—Nausea—Betamethasone—atopic dermatitis	0.00057	0.00061	CcSEcCtD
Lubiprostone—Nausea—Dexamethasone—atopic dermatitis	0.00057	0.00061	CcSEcCtD
Lubiprostone—CBR1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	0.000567	0.00852	CbGpPWpGaD
Lubiprostone—Dizziness—Prednisone—atopic dermatitis	0.000552	0.000592	CcSEcCtD
Lubiprostone—Vomiting—Prednisone—atopic dermatitis	0.000531	0.000569	CcSEcCtD
Lubiprostone—Rash—Prednisone—atopic dermatitis	0.000527	0.000564	CcSEcCtD
Lubiprostone—Dermatitis—Prednisone—atopic dermatitis	0.000526	0.000564	CcSEcCtD
Lubiprostone—Headache—Prednisone—atopic dermatitis	0.000523	0.000561	CcSEcCtD
Lubiprostone—Nausea—Prednisone—atopic dermatitis	0.000496	0.000531	CcSEcCtD
Lubiprostone—CBR1—Metabolism—PPARA—atopic dermatitis	0.000253	0.00379	CbGpPWpGaD
